ABCL — ABCELLERA BIOLOGICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ABCL?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 5 tracked investors who changed their ABCL position last quarter, 3 bought and 2 sold (60% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +3 tracked investors added or increased positions last quarter (Steve Cohen, George Soros, Izzy Englander)
- +5 tracked investors reported holding ABCL at their latest filing
- −2 tracked investors reduced or exited last quarter (2 reduced, 0 sold out)
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About ABCELLERA BIOLOGICS INC (ABCL)
ABCELLERA BIOLOGICS INC (ABCL) appears in the most recent 13F filings of 5 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $34M. Across recent filings, tracked investors recorded 8 new positions, 12 increased, 8 reduced, and 3 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ABCL
How many top investors track ABCL
A small number of top investors own this.
ABCL Ownership Composition
How ABCELLERA BIOLOGICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant80.4%
- Macro19.6%
Tracked investors currently reporting ABCL
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinSep 30, 2026Citadel AdvisorsShares2.4MValue$34.5M% Portfolio0.00%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares2MValue$29.7M% Portfolio0.01%
- Paul Tudor JonesSep 30, 2026Tudor Investment CorpShares956.7KValue$14M% Portfolio0.02%
- Steve CohenSep 30, 2026Point72 Asset ManagementShares136.2KValue$2M% Portfolio0.00%
- George SorosSep 30, 2026Soros Fund ManagementShares150KValue$2.2M% Portfolio0.03%
Previously held ABCL
These investors reported ABCL in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Stanley Druckenmiller | Duquesne Family Office | 659.8K | $3.8M | Dec 31, 2023 |
Recent activity
- Reduced$14M(-53.63%)Nov 16, 2026
- Increased$29.7M(293.04%)Nov 16, 2026
- New$2MNov 16, 2026
- Reduced$34.5M(-14.03%)Nov 16, 2026
- New$2.2MNov 13, 2026
- Increased$2M(67.27%)Nov 14, 2024
- Increased$4.3M(96.68%)Feb 14, 2025
- Reduced$1.9M(-41.34%)May 15, 2025
- Increased$11.7M(290.66%)Aug 14, 2025
- Reduced$6.1M(-27.01%)Feb 17, 2026
- Reduced$4.5M(-27.01%)May 15, 2026
- Reduced$4.1M(-59.94%)Aug 14, 2026
- Increased$4.3M(6.17%)Nov 14, 2024
- Increased$4.5M(124.96%)May 15, 2025
- Increased$10.9M(57.96%)Aug 14, 2025
- Reduced$7.5M(-53.25%)Nov 14, 2025
- Increased$7.6M(50.55%)Feb 17, 2026
- Increased$21.6M(46.40%)Aug 14, 2026
- New$3.3MFeb 17, 2026
- Increased$4M(17.70%)May 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- Increased$700.5K(160.82%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- $3.7MDec 9, 2025
- Increased$7.9M(26.59%)May 15, 2026
- Reduced$16.2M(-9.25%)Aug 14, 2026
- Unchanged$3.8M(0.00%)Feb 14, 2024
- $0(-100.00%)May 15, 2024
- $3MNov 14, 2023
- New$4.6MAug 14, 2024
- $5.7MMay 15, 2024
- $411KMay 15, 2024
Frequently asked questions
- How many institutional investors hold ABCL?
- 5 tracked institutional investors disclosed a position in ABCL (ABCELLERA BIOLOGICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ABCL?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ABCL, valued at $34M.
- Did institutional ownership of ABCL increase or decrease?
- Across recent 13F filings, tracked investors recorded 8 new positions, 12 increased, 8 reduced, and 3 fully exited ABCL.
- Where does this ABCL ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.